Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

Share Price is delayed by 15 minutes
Get Live Data
700.00    -10.00 (-1.41%)
Bid:
700.00
Ask:
706.00
Spread: 6.00 (0.857%)
Market Cap: £346.93m
ELIX Live PriceLast checked at - London Stock Exchange

Intraday Elixirr International Share Chart

Board Changes

10 Dec 2024 07:00

RNS Number : 4806P
Elixirr International PLC
10 December 2024
 

 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or "Group")

Board Changes

Elixirr International plc (AIM:ELIX), an established, global, award-winning, challenger consultancy, announces the following changes to its Board of Directors.

Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures. Stephen Newton will continue as Chief Executive Officer.

The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.

A further announcement will be made in due course regarding Nick's formal appointment to the board, containing requisite disclosures in accordance with Schedule Two, paragraph (g) of the AIM Rules for Companies.

Commenting on the board changes, Founder & CEO of Elixirr, Stephen Newton said:

"We are delighted to announce the appointments of Graham and Nick as Deputy CEO and CFO respectively. Their deep understanding of the business, together with their technical knowledge and market expertise will further strengthen the Board and support the Company as it continues its strong trajectory of growth. Graham has operated as de facto Deputy Chief Executive Officer for several years working side-by-side with me every day, and Nick has performed exceptionally as our Finance Director and Company Secretary since joining us in 2020. We will continue to work together as a team in the years going forward as we continue to disrupt the consulting market.

The Board, and I personally, wish to thank Ian for his significant contributions as a Board Director and we look forward to his continued counsel as an ongoing advisor to the Board as well as receive his guidance and wisdom on special projects, particularly around M&A."

Enquiries: 

For enquiries, please refer to our Investor Contacts page:

https://www.elixirr.com/investors/investor-contacts

Elixirr International plc +44 (0)20 7220 5410  

Stephen Newton, Chief Executive Officer

Graham Busby, Chief Financial Officer

investor-relations@elixirr.com

Cavendish Capital Markets Ltd (Nominated Adviser & Broker) +44 (0)20 7220 0500

Stephen Keys, Callum Davidson (Corporate Finance),

Sunila De Silva (ECM)

 

About Elixirr International plc

Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies.

Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr has been quoted on the AIM market of the London Stock Exchange since 2020. In addition to strong organic growth, Elixirr has acquired seven boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum, Insigniam and Hypothesis - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.

 

 This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURUNRSOUUARA
Date   Source Headline
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
24th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20213:52 pmRNSResult of Secondary Placing
12th May 20212:09 pmRNSProposed Secondary Placing
30th Apr 20214:15 pmRNSResult of General Meeting
27th Apr 20214:12 pmRNSGrant of Share Options
14th Apr 20217:00 amRNSCircular and Notice of GM
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:01 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSAcquisition of Retearn Group Limited
12th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSDirector/PCA Dealings
8th Feb 20218:00 amRNSTrading Update
21st Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20208:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSHolding(s) in Company
16th Dec 20207:00 amRNSHolding(s) in Company
11th Dec 20207:00 amRNSResult of Secondary Placing
10th Dec 20203:57 pmRNSProposed Secondary Placing
13th Nov 20207:00 amRNSPDMR Dealing
2nd Nov 20202:05 pmRNSPDMR Dealing
29th Oct 20207:00 amRNSAcquisition of Coast Digital Limited
19th Oct 20207:00 amRNSTrading Update
15th Sep 20207:00 amRNSInterim Results
11th Aug 20207:00 amRNSPCA Shareholding
27th Jul 20207:00 amRNSPDMR Dealing
22nd Jul 20207:00 amRNSPCA Dealing
14th Jul 20205:15 pmRNSHolding(s) in Company
9th Jul 20208:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.